Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.50
15.02.24
-
15.02.25
-3.09%
17.02.24

Risky Investment
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.35
05.02.24
-
05.02.25
29.34%
06.02.24

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
Coherus Bioscien.

Start price
Target price
Perf. (%)
€1.88
05.02.24
-
05.02.25
33.90%
17.02.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.32
05.02.24
-
05.02.25
-43.81%
08.02.24

Good culture
Risky Investment
No uniques
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.40
04.02.24
€20.00
30.11.25
-77.89%
13.05.24

Could be very worthwhile Investment >20% year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€0.98
04.02.24
€1.50
31.10.25
14.29%
29.04.24

Could be very worthwhile Investment >20% year
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€22.48
31.01.24
-
29.02.24
230.87%
01.03.24

buy
PVA TePla AG

Start price
Target price
Perf. (%)
€21.86
30.01.24
-
30.01.25
2.01%
15.02.24

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€3.75
29.01.24
-
29.01.25
-2.03%
03.02.24

Could be very worthwhile Investment >20% year
buy
RumbleON Inc.

Start price
Target price
Perf. (%)
€6.70
26.01.24
-
26.02.24
1.49%
27.02.24

Small challenges to pay loans and raise capital
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€76.00
25.01.24
€110.00
31.03.26
-0.66%
02.02.24

Could be very worthwhile Investment >20% year
buy
Kura Oncology Inc

Start price
Target price
Perf. (%)
€17.70
25.01.24
€16.00
31.08.25
9.60%
02.02.24

Could be very worthwhile Investment >20% year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.21
23.01.24
-
23.01.25
-15.48%
03.02.24

Probably not worthwhile Investment
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€3.38
22.01.24
-
22.01.25
14.50%
03.02.24

Could be very worthwhile Investment >20% year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.92
22.01.24
-
22.01.25
-36.03%
03.02.24

Probably not worthwhile Investment
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.67
21.01.24
-
21.01.25
18.80%
03.02.24

Could be worthwhile Investment >10% per year
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€2.44
21.01.24
-
21.01.25
23.55%
03.02.24

Could be worthwhile Investment >10% per year
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.91
21.01.24
-
21.01.25
7.87%
03.02.24

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€75.00
21.01.24
-
21.01.25
-2.67%
03.02.24

Could be worthwhile Investment >10% per year
buy
Stef Tfe

Start price
Target price
Perf. (%)
€118.60
20.01.24
-
20.01.25
2.70%
03.02.24

Could be worthwhile Investment >10% per year
buy
Mercialys Inh.

Start price
Target price
Perf. (%)
€10.56
20.01.24
-
20.01.25
-0.57%
03.02.24

Could be worthwhile Investment >10% per year
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.95
18.01.24
-
18.01.25
-14.44%
21.01.24

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.98
18.01.24
-
18.01.25
-3.63%
20.01.24

Could be worthwhile Investment >10% per year
buy
Trend Micro Inc.

Start price
Target price
Perf. (%)
€51.30
16.01.24
-
16.01.25
6.63%
15.02.24

buy
Trend Micro Inc.

Start price
Target price
Perf. (%)
€51.30
16.01.24
-
16.01.25
6.63%
15.02.24